Real World Outcomes with Venetoclax (Ven)-Based Therapies in Patients with Heavily Pretreated Relapsed/Refractory Multiple Myeloma (RRMM): A Mayo Clinic Comprehensive Cancer Center (MCCC) Experience
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Ricardo D. Parrondo, Saurav Das, Hanna Sledge, Abiola Bolarinwa, Jamie Elliott, Andre Fernandez, David O. Hodge, Leif Bergsagel, Rafael Fonseca, Prashant Kapoor, Francis Buadi, Morie A. Gertz, Angela Dispenzieri, Vivek Roy, Taimur Sher, Moritz Binder, Nadine Abdallah, Saurabh Chhabra, S. Vincent Rajkumar, Wilson I. Gonsalves, Joselle Cook, David Dingli, Saurabh Zanwar, Yi Lin, Eli Muchtar, Caitlin Wilson, Udit Yadav, Rahma M Warsame, J E Wiedmeier-Nutor, Taxiarchis Kourelis, Nelson Leung, Madhu Nagaraj, Mustaqeem A. Siddiqui, Linda B. Baughn, Shaji Kumar, Asher A. Chanan-Khan, Sikander Ailawadhi
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405042018